ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

Abstracts From AACR Annual Meeting

June 4, 1976

Needed Enhancement Or Unfunded Mandate? New NCI Program To Merge CCOP, NCCCP

July 13, 2012

Nucynta ER Approved For Managing Chronic Pain In Adults

September 30, 2011

In Brief: Carter Wants His Own Man, So Cooper Is Out; New Preventive Oncology Society Established

January 14, 1977

ACCC Members To Lobby, Hear Discussion on Oncology Unit

January 6, 1978

FDA Approves HPV Test

April 25, 2003